Elemental Enzymes welcomes Brett Begemann as chair
Elemental Enzymes, a St. Louis company that develops and markets sustainable solutions to aid in crop nutrient absorption and immune response, is pleased to welcome Brett Begemann as chair of its board of directors, as of Oct. 1, 2023.
In 2021, Begemann retired from Bayer Crop Science, where he spent three years as its Chief Operating Officer after Bayer acquired Monsanto. Prior to 2018, as president and COO for Monsanto, he led efforts to increase manufacturing and supply chain efficiency globally, as well as to connect farmers with solutions for better harvests. He started his career with Monsanto in 1983 in sales and marketing, later moving into executive management with titles including executive vice president and chief commercial officer.
Begemann will be responsible for ensuring the effectiveness of the board in setting and implementing corporate direction for Elemental Enzymes. He will lead the board’s focus on strategic direction for the company, set meeting agendas, be responsible for setting high governance standards and remain available to the CEO to advise on company strategy and operations.
“I am glad to welcome Brett to the board, and to Elemental, where we are looking forward to having a close and productive relationship to grow the company even more in the coming months and years,” said Brian Thompson, Ph.D., CEO of Elemental Enzymes.